Hologic (HOLX) is currently trading at a forward price-to-earnings (P/E) multiple of 17.62X, well below the industry average of 32.42X. The company, specializing in medical devices for women’s health, also stands out with respect to industry peers Globus Medical (GMED) and Masimo (MASI) , which trade at a higher P/E of 24.25X and 39.01X, respectively. Hologic currently has a Value Score of B.Price-to-Earnings Forward Twelve Months (F12M)Image Source: Zacks Investment ResearchYesterday, HOLX stock ended the ...